Spherulites of amyloid-beta42 in vitro and in Alzheimer's disease
Related Experiment Video
Updated: Jun 13, 2026

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
Published on: July 6, 2019
Christopher Exley1, Emily House, Joanna F Collingwood
1The Birchall Centre, Lennard-Jones Laboratories, Keele University, Staffordshire, UK. c.exley@chem.keele.ac.uk
Abstract:
Several amyloidogenic proteins including insulin, beta-lactoglobulin, and albumin form spherulites in vitro under non-physiological conditions. These micrometer-sized, roughly spherical structures are composed of ordered arrays of amyloid fibrils in radial arrangements which, characteristically, show a typical Maltese cross pattern of light extinction under the polarizing microscope. The physiological significance of amyloid spherulites is unknown though in Alzheimer's disease, senile plaques composed primarily of beta sheets of amyloid-beta (Abeta)42 have, very occasionally, been shown to give a Maltese cross pattern of light extinction under crossed polarizers. Herein we describe the first observation of the formation in vitro of spherulites of Abeta42. They were formed under near-physiological conditions in which the beta sheet conformation of pre-formed aggregates of Abeta42 had been abolished following the addition of an excess of copper. Incubation of these preparations at 37 degrees C for up to 9 months resulted in the formation of globular structures, 5-20 microm in diameter, which exhibited a Maltese cross pattern of light extinction typical of spherulites. Near-identical spherulitic structures were also observed in abundance in 30 microm thick sections of Alzheimer's disease brain tissue. Synchrotron x-ray fluorescence showed that the location of these spherulites in AD tissue coincided with locally elevated concentrations of tissue copper. The formation in vitro of spherulites of Abeta42 which morphologically appeared analogous to spherulitic structures observed in vivo strongly supports the hypothesis that spherulites and senile plaques in AD tissue are one and the same structures and that their ultimate formation may involve copper.
Insights
Researchers observed amyloid-beta (Abeta)42 forming spherulites under near-physiological conditions, mimicking structures found in Alzheimer
Area of Science:
- Biochemistry
- Neuroscience
- Materials Science
Background:
- Amyloidogenic proteins like insulin can form spherulites in vitro.
- Amyloid spherulites are ordered fibril arrays with a Maltese cross pattern.
- The role of spherulites in Alzheimer's disease (AD) is unclear, though some plaques show similar patterns.
Purpose of the Study:
- To investigate the in vitro formation of amyloid-beta (Abeta)42 spherulites.
- To explore the potential role of copper in Abeta42 aggregation and spherulite formation.
- To compare in vitro formed Abeta42 spherulites with structures found in AD brain tissue.
Main Methods:
- Disruption of Abeta42 beta-sheet conformation with excess copper.
- Incubation of modified Abeta42 at 37°C for up to 9 months.
- Analysis of Abeta42 structures using polarizing microscopy and synchrotron X-ray fluorescence.
Main Results:
- Formation of Abeta42 spherulites (5-20 micrometers) with Maltese cross patterns under near-physiological conditions.
- Observation of similar spherulitic structures in Alzheimer's disease brain tissue.
- Correlation between spherulite location in AD tissue and elevated copper concentrations.
Conclusions:
- In vitro Abeta42 spherulites resemble in vivo structures found in AD brain.
- This supports the hypothesis that senile plaques and spherulites in AD are similar.
- Copper may play a crucial role in the ultimate formation of these structures in Alzheimer's disease.
More Related Videos
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology

